Triple
T6005124
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Ionis Pharmaceuticals, Inc. |
E133689
|
entity |
| Predicate | drugDiscoveryApproach |
P1717
|
FINISHED |
| Object | RNA-targeted therapeutics |
—
|
LITERAL FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: RNA-targeted therapeutics | Statement: [Ionis Pharmaceuticals, Inc., drugDiscoveryApproach, RNA-targeted therapeutics]
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: drugDiscoveryApproach Context triple: [Ionis Pharmaceuticals, Inc., drugDiscoveryApproach, RNA-targeted therapeutics]
-
A.
discoveryMethod
Indicates the process, technique, or approach by which something was found, detected, or identified.
-
B.
hasMolecularTarget
Indicates that one entity (such as a drug or compound) is directed toward, binds to, or specifically interacts with a particular molecular target (such as a protein, receptor, or gene).
-
C.
hasDrugBankID
Indicates that an entity is associated with a specific identifier from the DrugBank database.
-
D.
potentialTherapeuticUse
Indicates that something is being considered or investigated as a possible treatment or therapy for a condition or disease.
-
E.
researchApproach
chosen
Indicates the methodological strategy or set of methods used to conduct and structure a research activity or investigation.
- F. None of above.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69c00872444c8190bfaf1739dcec765c |
completed | March 22, 2026, 3:19 p.m. |
| NER | Named-entity recognition | batch_69c04f10d18081908c351170b7f58d3d |
completed | March 22, 2026, 8:20 p.m. |
| PD | Predicate disambiguation | batch_69c049e4daf4819099bf870dc700e0a2 |
completed | March 22, 2026, 7:58 p.m. |
Created at: March 22, 2026, 4:06 p.m.